About

Provided by Goodwin

Our Technology, Life Sciences, and Emerging Companies Practice is rooted in partnering with, and supporting, companies on their journey throughout the corporate lifecycle, no matter the stage or growth path they choose. Goodwin is highly regarded in these verticals as a result of our tenured experience, vast platform, and deep expertise guiding emerging technology and life sciences companies throughout their maturation and ultimately through exit and beyond. By partnering with us for their most meaningful transactions, our clients are able to further maximize their position within the marketplace and fuel their growth. We work with our clients across the full suite of company and investor lifecycle needs, including through:

·      Company Formation

·      Financings (early- through late-stage)

·      Capital Markets Transactions, such as IPOs, SPACs, or Direct Listings

·      M+A Transactions (Buy- and Sell-Side, #1 in Global M&A by deal count per Refinitiv in 2022)

·      Regulatory + FDA Matters

·      Tax

·      Technology Transaction, including IP Transactions, such as Licensing, Collaborations, and Joint Ventures, in addition to Patent and Trademark Prosecution, Portfolio Management and Diligence

·      Offshore + Cross-Border Transactions

·      Tender Offers

·      Debt Transactions

·      Data Privacy + Cybersecurity

·      Executive Compensation


Chambers Review

Provided by Chambers
Startups & Emerging Companies - USA - Nationwide
1
Band 1
What the team is known for

Goodwin is a leading player in the startups and emerging companies field, aiding biotech, e-commerce and digital media entities, among others, throughout their development from creation to sale or IPO. The team is also experienced in matters such as intellectual property and M&A. It boasts a significant investor-side practice, acting for a number of leading venture capital funds. The firm benefits from a broad geographical spread, from San Francisco and Silicon Valley to Boston and New York.

Work Highlights

Provided by Goodwin
  • Goodwin provided counsel to Coalition on a Series F financing.

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers
Anthony McCusker
1
Anthony McCusker
1
Band 1

Anthony McCusker advises both startups and investors operating in a range of sectors, including fintech and biotech.

"He's a real expert and he's super experienced."

John J Egan III
3
John J Egan III
3
Band 3

John Egan routinely represents emerging companies from the technology sector in high-value financings. He is cochair of the firm's technology and emerging companies group.

Patrick Mitchell
3
Patrick Mitchell
3
Band 3

Patrick Mitchell is routinely called upon to provide counsel to growth equity and venture capital firms. His broad practice involves advising on transactions and portfolio investments.

"Pat is super practical, very solutions-oriented and is able to craft winning solutions."

Mitchell S Bloom
4
Mitchell S Bloom
4
Band 4

Mitchell Bloom draws acclaim for his representation of startups in the life science sector. He has particular experience in transactions involving emerging biotechnology companies.

Jon Novotny
U
Jon Novotny
U
Up and Coming

Jon Novotny focuses his practice on advising clients on early-stage financings concerning organizations in the technology sector.

"An exceptional lawyer who is very commercially savvy."

Michelle Knoop
U
Michelle Knoop
U
Up and Coming

Michelle Knoop is developing a strong practice advising companies on funding cycles and providing general corporate advice.

"Michelle is a fierce negotiator, she's phenomenal."

Ranked Lawyers at
Goodwin

Provided by Chambers
Filter by
Band

USA - Nationwide

Startups & Emerging Companies

Anthony McCusker
1
Anthony McCusker
1
Band 1
John J Egan III
3
John J Egan III
3
Band 3
Patrick Mitchell
3
Patrick Mitchell
3
Band 3
Mitchell S Bloom
4
Mitchell S Bloom
4
Band 4
Jon Novotny
U
Jon Novotny
U
Up and Coming
Michelle Knoop
U
Michelle Knoop
U
Up and Coming